Skip to content

ORBIMED ADVISORS LLC: PRLD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on PRLD, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 13,724,571 PRLD shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 13,724,571 shares
    Change vs previous 13F 0 shares

    0.98% of the 13F portfolio, value $53,663,073.

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

  2. period ended2026-06-30
    13F 13,724,571 shares
    Change vs previous 13F +2,815,315 shares

    1.39% of the 13F portfolio, value $73,151,963.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 10,909,256 shares
    Change vs previous 13F 0 shares

    0.81% of the 13F portfolio, value $37,309,656.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 10,909,256 shares
    Change vs previous 13F 0 shares

    0.65% of the 13F portfolio, value $31,636,842.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 10,909,256 shares
    Change vs previous 13F 0 shares

    0.38% of the 13F portfolio, value $15,709,329.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 10,909,256 shares
    Change vs previous 13F 0 shares

    0.22% of the 13F portfolio, value $8,829,952.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2025-03-31
    13F 10,909,256 shares
    Change vs previous 13F 0 shares

    0.2% of the 13F portfolio, value $8,378,309.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-12-31
    13F 10,909,256 shares
    Change vs previous 13F not available

    0.29% of the 13F portfolio, value $13,909,301.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).